Treatment of Uremic Pruritus With Inhaled PA101B in Patients With End-Stage Renal Disease Requiring Hemodialysis
Phase of Trial: Phase II
Latest Information Update: 07 Apr 2017
At a glance
- Drugs Sodium cromoglicate (Primary)
- Indications Pruritus
- Focus Proof of concept; Therapeutic Use
- Sponsors Patara Pharma
- 05 Apr 2017 Status changed from active, no longer recruiting to completed.
- 20 Aug 2016 This trial has been completed in Poland according to European Clinical Trials Database record.
- 03 May 2016 Status changed from recruiting to active, no longer recruiting.